These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 1458763)

  • 21. Stereoselective plasma protein binding and target tissue distribution of clausenamide enantiomers in rats.
    Zhu CJ; Zhang JT
    Chirality; 2009 Mar; 21(3):402-6. PubMed ID: 18655159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereoselective pharmacokinetics of cetirizine in the guinea pig: role of protein binding.
    Gupta A; Hammarlund-Udenaes M; Chatelain P; Massingham R; Jonsson EN
    Biopharm Drug Dispos; 2006 Sep; 27(6):291-7. PubMed ID: 16791848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma protein binding of propranolol enantiomers as a major determinant of their stereoselective tissue distribution in rats.
    Takahashi H; Ogata H; Kanno S; Takeuchi H
    J Pharmacol Exp Ther; 1990 Jan; 252(1):272-8. PubMed ID: 2299595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Lombardo F; Obach RS; Shalaeva MY; Gao F
    J Med Chem; 2004 Feb; 47(5):1242-50. PubMed ID: 14971904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma Protein Binding of Highly Bound Drugs Determined With Equilibrium Gel Filtration of Nonradiolabeled Compounds and LC-MS/MS Detection.
    Isbell J; Yuan D; Torrao L; Gatlik E; Hoffmann L; Wipfli P
    J Pharm Sci; 2019 Feb; 108(2):1053-1060. PubMed ID: 30336155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct determination of the ratio of unbound fraction in plasma to unbound fraction in microsomal system (fu p/fu mic) for refined prediction of phase I mediated metabolic hepatic clearance.
    Deshmukh SV; Harsch A
    J Pharmacol Toxicol Methods; 2011; 63(1):35-9. PubMed ID: 20433934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein binding of drugs in plasma, interstitial fluid and tissues: effect on pharmacokinetics.
    Faed EM
    Eur J Clin Pharmacol; 1981; 21(1):77-81. PubMed ID: 7333350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The bioanalytical challenge of determining unbound concentration and protein binding for drugs.
    Nilsson LB
    Bioanalysis; 2013 Dec; 5(24):3033-50. PubMed ID: 24320129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of compound binding to plasma proteins.
    Dow N
    Curr Protoc Pharmacol; 2006 Oct; Chapter 7():Unit7.5. PubMed ID: 22294178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prediction of enantiomeric differences in the pharmacokinetic parameters of drugs by using a physiological perfusion model].
    Piotrovskiĭ VK; Shvachko EV; Trnovec T
    Eksp Klin Farmakol; 1994; 57(5):37-40. PubMed ID: 7696904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pH on plasma protein binding in equilibrium dialysis.
    Kochansky CJ; McMasters DR; Lu P; Koeplinger KA; Kerr HH; Shou M; Korzekwa KR
    Mol Pharm; 2008; 5(3):438-48. PubMed ID: 18345638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-depth insight into the methods of plasma protein-drug interaction studies: Comparison of capillary electrophoresis-frontal analysis, isothermal titration calorimetry, circular dichroism and equilibrium dialysis.
    Nevídalová H; Michalcová L; Glatz Z
    Electrophoresis; 2018 Feb; 39(4):581-589. PubMed ID: 29110326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-protein-binding determination of stilbene glucoside using cloud-point extraction and comparison with ultrafiltration and equilibrium dialysis.
    Wang C; Wang Q; Yuan Z; Liu W; Gu J; Zhang L
    Drug Dev Ind Pharm; 2010 Mar; 36(3):307-14. PubMed ID: 19670965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of recovery on fraction unbound using equilibrium dialysis.
    Di L; Umland JP; Trapa PE; Maurer TS
    J Pharm Sci; 2012 Mar; 101(3):1327-35. PubMed ID: 22161810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review.
    Lambrinidis G; Vallianatou T; Tsantili-Kakoulidou A
    Adv Drug Deliv Rev; 2015 Jun; 86():27-45. PubMed ID: 25819487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug distribution and binding.
    Oie S
    J Clin Pharmacol; 1986; 26(8):583-6. PubMed ID: 3793947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of ethopropazine enantiomers in the rat: tissue distribution and plasma protein binding.
    Brocks DR; Maboudian-Esfahani M
    J Pharm Pharm Sci; 1999; 2(1):23-9. PubMed ID: 10951659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer.
    Skoczen SL; Stern ST
    Methods Mol Biol; 2018; 1682():223-239. PubMed ID: 29039106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methods of determination, physico-chemical properties and pharmacokinetic signifance of plasma protein binding of drugs].
    Krieglstein J
    Arzneimittelforschung; 1973 Nov; 23(11):1527-9. PubMed ID: 4801656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.